Share capital
Total number of shares and voting rights comprising Exosens' Share Capital
(article L.233-8-II of the French Commercial Code and article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Date | Total number of issued shares | Total number of voting rights |
---|---|---|
At 30 June 2024 | 50 782 552 | Number of theoretical voting rights: 50,782,552 Number of exercisable voting rights*: 50,782,552 |
* After deduction of any treasury shares without voting rights
Shareholders
Shareholders | Number of shares | % of share capital | % of voting rights |
---|---|---|---|
HLD | 26,778,438 | 52.73% | 52.73% |
Bpifrance Participations | 2,285,260 | 4.50% | 4.50% |
Public float | 17,839,743 | 35.13% | 35.13% |
Minority shareholders | 3,879,111 | 7.64% | 7.64% |
Total | 50,782,552 | 100% | 100% |
Analysts
The following list of analysts is for informational purposes only and does not constitute an endorsement by Exosens of any of the securities analysts or brokerage firms listed. Exosens does not guarantee the completeness of this list, which is subject to change.
In addition, any opinions, estimates or forecasts regarding Exosens' performance made by these analysts are not opinions, estimates or forecasts of Exosens or its management. Exosens does not represent or endorse the accuracy of these analysts' information, conclusions or recommendations.
Firm | Analyst |
---|---|
Kepler Chevreux | Aymeric Poulain |
Kepler Chevreux | Hugo Paternoster |
BNP Paribas | Laurent Gelebart |
BNP Paribas | Tristan Sanson |
Oddo | Aurélien Sivignon |
Oddo | Yan Derocles |
JP Morgan | David H Perry |
Bernstein SG | Aleksander Peterc |
Citibank | Charles J Armitage |